Report Detail

Request for Sample of this report

Pharma & Healthcare Global CRISPR-associated Nucleases Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4609136
    • |
  • 19 August, 2024
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems, which form an adaptive immune system in bacteria, have been modified for genome engineering. CRISPR is a technology that can be employed to edit genes. Moreover, CRISPR technology has the potential to transform medicine and make us not only treat but also prevent many diseases.The core of CRISPR is the "Cas" proteins found in bacteria, where they help defend against viruses. CRISPR-associated (Cas) nucleases are furnishing transformative technologies for genome editing and functional genomics.
According to our (Global Info Research) latest study, the global CRISPR-associated Nucleases market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The Cas9 protein is the most commonly used by scientists. They recognize their substrate sequence via a Protospacer Adjacent Motif (PAM) sequence and base-pairing of the target sequence by a guide RNA (gRNA) borne by the nuclease. Upon target recognition, Cas nucleases induce a double-strand break, following which the cell's repair machinery can be co-opted to alter the genomic sequence.
This report is a detailed and comprehensive analysis for global CRISPR-associated Nucleases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CRISPR-associated Nucleases market size and forecasts, in consumption value ($ Million), 2019-2030
Global CRISPR-associated Nucleases market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CRISPR-associated Nucleases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CRISPR-associated Nucleases market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRISPR-associated Nucleases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRISPR-associated Nucleases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, GenScript, Integrated DNA Technologies, Inc., Aldevron, Merck, Horizon Discovery, Agilent, OriGene Technologies, Inc, New England Biolabs, NIPPON GENE CO., LTD., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRISPR-associated Nucleases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
CRISPR-associated Nucleases market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cas9
Cas12
Cas13
Others
Market segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
Market segment by players, this report covers
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR-associated Nucleases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR-associated Nucleases, with revenue, gross margin, and global market share of CRISPR-associated Nucleases from 2019 to 2024.
Chapter 3, the CRISPR-associated Nucleases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRISPR-associated Nucleases market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR-associated Nucleases.
Chapter 13, to describe CRISPR-associated Nucleases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CRISPR-associated Nucleases by Type
    • 1.3.1 Overview: Global CRISPR-associated Nucleases Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global CRISPR-associated Nucleases Consumption Value Market Share by Type in 2023
    • 1.3.3 Cas9
    • 1.3.4 Cas12
    • 1.3.5 Cas13
    • 1.3.6 Others
  • 1.4 Global CRISPR-associated Nucleases Market by Application
    • 1.4.1 Overview: Global CRISPR-associated Nucleases Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Gene Editing Cell Line Construction
    • 1.4.3 Animal Models
    • 1.4.4 Bioagriculture
    • 1.4.5 Gene Therapy
    • 1.4.6 Other
  • 1.5 Global CRISPR-associated Nucleases Market Size & Forecast
  • 1.6 Global CRISPR-associated Nucleases Market Size and Forecast by Region
    • 1.6.1 Global CRISPR-associated Nucleases Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global CRISPR-associated Nucleases Market Size by Region, (2019-2030)
    • 1.6.3 North America CRISPR-associated Nucleases Market Size and Prospect (2019-2030)
    • 1.6.4 Europe CRISPR-associated Nucleases Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific CRISPR-associated Nucleases Market Size and Prospect (2019-2030)
    • 1.6.6 South America CRISPR-associated Nucleases Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa CRISPR-associated Nucleases Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific CRISPR-associated Nucleases Product and Solutions
    • 2.1.4 Thermo Fisher Scientific CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 GenScript
    • 2.2.1 GenScript Details
    • 2.2.2 GenScript Major Business
    • 2.2.3 GenScript CRISPR-associated Nucleases Product and Solutions
    • 2.2.4 GenScript CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GenScript Recent Developments and Future Plans
  • 2.3 Integrated DNA Technologies, Inc.
    • 2.3.1 Integrated DNA Technologies, Inc. Details
    • 2.3.2 Integrated DNA Technologies, Inc. Major Business
    • 2.3.3 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Product and Solutions
    • 2.3.4 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
  • 2.4 Aldevron
    • 2.4.1 Aldevron Details
    • 2.4.2 Aldevron Major Business
    • 2.4.3 Aldevron CRISPR-associated Nucleases Product and Solutions
    • 2.4.4 Aldevron CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Aldevron Recent Developments and Future Plans
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck CRISPR-associated Nucleases Product and Solutions
    • 2.5.4 Merck CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Merck Recent Developments and Future Plans
  • 2.6 Horizon Discovery
    • 2.6.1 Horizon Discovery Details
    • 2.6.2 Horizon Discovery Major Business
    • 2.6.3 Horizon Discovery CRISPR-associated Nucleases Product and Solutions
    • 2.6.4 Horizon Discovery CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Horizon Discovery Recent Developments and Future Plans
  • 2.7 Agilent
    • 2.7.1 Agilent Details
    • 2.7.2 Agilent Major Business
    • 2.7.3 Agilent CRISPR-associated Nucleases Product and Solutions
    • 2.7.4 Agilent CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Agilent Recent Developments and Future Plans
  • 2.8 OriGene Technologies, Inc
    • 2.8.1 OriGene Technologies, Inc Details
    • 2.8.2 OriGene Technologies, Inc Major Business
    • 2.8.3 OriGene Technologies, Inc CRISPR-associated Nucleases Product and Solutions
    • 2.8.4 OriGene Technologies, Inc CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 OriGene Technologies, Inc Recent Developments and Future Plans
  • 2.9 New England Biolabs
    • 2.9.1 New England Biolabs Details
    • 2.9.2 New England Biolabs Major Business
    • 2.9.3 New England Biolabs CRISPR-associated Nucleases Product and Solutions
    • 2.9.4 New England Biolabs CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 New England Biolabs Recent Developments and Future Plans
  • 2.10 NIPPON GENE CO., LTD.
    • 2.10.1 NIPPON GENE CO., LTD. Details
    • 2.10.2 NIPPON GENE CO., LTD. Major Business
    • 2.10.3 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Product and Solutions
    • 2.10.4 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 NIPPON GENE CO., LTD. Recent Developments and Future Plans
  • 2.11 Novoprotein
    • 2.11.1 Novoprotein Details
    • 2.11.2 Novoprotein Major Business
    • 2.11.3 Novoprotein CRISPR-associated Nucleases Product and Solutions
    • 2.11.4 Novoprotein CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Novoprotein Recent Developments and Future Plans
  • 2.12 Applied Biological Materials Inc. (abm)
    • 2.12.1 Applied Biological Materials Inc. (abm) Details
    • 2.12.2 Applied Biological Materials Inc. (abm) Major Business
    • 2.12.3 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Product and Solutions
    • 2.12.4 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Applied Biological Materials Inc. (abm) Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CRISPR-associated Nucleases Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of CRISPR-associated Nucleases by Company Revenue
    • 3.2.2 Top 3 CRISPR-associated Nucleases Players Market Share in 2023
    • 3.2.3 Top 6 CRISPR-associated Nucleases Players Market Share in 2023
  • 3.3 CRISPR-associated Nucleases Market: Overall Company Footprint Analysis
    • 3.3.1 CRISPR-associated Nucleases Market: Region Footprint
    • 3.3.2 CRISPR-associated Nucleases Market: Company Product Type Footprint
    • 3.3.3 CRISPR-associated Nucleases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CRISPR-associated Nucleases Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global CRISPR-associated Nucleases Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global CRISPR-associated Nucleases Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global CRISPR-associated Nucleases Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America CRISPR-associated Nucleases Consumption Value by Type (2019-2030)
  • 6.2 North America CRISPR-associated Nucleases Market Size by Application (2019-2030)
  • 6.3 North America CRISPR-associated Nucleases Market Size by Country
    • 6.3.1 North America CRISPR-associated Nucleases Consumption Value by Country (2019-2030)
    • 6.3.2 United States CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 6.3.3 Canada CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico CRISPR-associated Nucleases Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe CRISPR-associated Nucleases Consumption Value by Type (2019-2030)
  • 7.2 Europe CRISPR-associated Nucleases Consumption Value by Application (2019-2030)
  • 7.3 Europe CRISPR-associated Nucleases Market Size by Country
    • 7.3.1 Europe CRISPR-associated Nucleases Consumption Value by Country (2019-2030)
    • 7.3.2 Germany CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 7.3.3 France CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 7.3.5 Russia CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 7.3.6 Italy CRISPR-associated Nucleases Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR-associated Nucleases Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific CRISPR-associated Nucleases Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific CRISPR-associated Nucleases Market Size by Region
    • 8.3.1 Asia-Pacific CRISPR-associated Nucleases Consumption Value by Region (2019-2030)
    • 8.3.2 China CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 8.3.3 Japan CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 8.3.5 India CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 8.3.7 Australia CRISPR-associated Nucleases Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America CRISPR-associated Nucleases Consumption Value by Type (2019-2030)
  • 9.2 South America CRISPR-associated Nucleases Consumption Value by Application (2019-2030)
  • 9.3 South America CRISPR-associated Nucleases Market Size by Country
    • 9.3.1 South America CRISPR-associated Nucleases Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina CRISPR-associated Nucleases Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR-associated Nucleases Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa CRISPR-associated Nucleases Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa CRISPR-associated Nucleases Market Size by Country
    • 10.3.1 Middle East & Africa CRISPR-associated Nucleases Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia CRISPR-associated Nucleases Market Size and Forecast (2019-2030)
    • 10.3.4 UAE CRISPR-associated Nucleases Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 CRISPR-associated Nucleases Market Drivers
  • 11.2 CRISPR-associated Nucleases Market Restraints
  • 11.3 CRISPR-associated Nucleases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CRISPR-associated Nucleases Industry Chain
  • 12.2 CRISPR-associated Nucleases Upstream Analysis
  • 12.3 CRISPR-associated Nucleases Midstream Analysis
  • 12.4 CRISPR-associated Nucleases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CRISPR-associated Nucleases. Industry analysis & Market Report on CRISPR-associated Nucleases is a syndicated market report, published as Global CRISPR-associated Nucleases Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of CRISPR-associated Nucleases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,288.60
    		4,932.90
    		6,577.20
    		540,096.00
    		810,144.00
    		1,080,192.00
    		293,851.20
    		440,776.80
    		587,702.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo